Cadrenal Therapeutics, Inc. (CVKD)
Nasdaq: CVKD · CIK 0001937993 · United States
Every official Cadrenal Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CVKD filings
Cadrenal Therapeutics, Inc. documents
- Cadrenal Therapeutics, Inc. 10-K 2026CVKD 10-K 2026: annual report for fiscal 2026
- Cadrenal Therapeutics, Inc. 10-K 2025CVKD 10-K 2025: annual report for fiscal 2025
- Cadrenal Therapeutics, Inc. 10-K 2024CVKD 10-K 2024: annual report for fiscal 2024
- Cadrenal Therapeutics, Inc. 10-K 2023CVKD 10-K 2023: annual report for fiscal 2023
- Cadrenal Therapeutics, Inc. 10-K 2022CVKD 10-K 2022: annual report for fiscal 2022
- Cadrenal Therapeutics, Inc. 10-Q 2026CVKD 10-Q 2026: quarterly report for fiscal 2026
- Cadrenal Therapeutics, Inc. 10-Q 2025CVKD 10-Q 2025: quarterly report for fiscal 2025
- Cadrenal Therapeutics, Inc. 10-Q 2024CVKD 10-Q 2024: quarterly report for fiscal 2024
- Cadrenal Therapeutics, Inc. 10-Q 2023CVKD 10-Q 2023: quarterly report for fiscal 2023
- Cadrenal Therapeutics, Inc. 10-Q 2022CVKD 10-Q 2022: quarterly report for fiscal 2022
- Cadrenal Therapeutics, Inc. 8-K 2026CVKD 8-K 2026: current report for fiscal 2026
- Cadrenal Therapeutics, Inc. 8-K 2025CVKD 8-K 2025: current report for fiscal 2025
- Cadrenal Therapeutics, Inc. 8-K 2024CVKD 8-K 2024: current report for fiscal 2024
- Cadrenal Therapeutics, Inc. 8-K 2023CVKD 8-K 2023: current report for fiscal 2023
- Cadrenal Therapeutics, Inc. 8-K 2022CVKD 8-K 2022: current report for fiscal 2022
- Cadrenal Therapeutics, Inc. DEF 14A 2026CVKD DEF 14A 2026: proxy statement for fiscal 2026
- Cadrenal Therapeutics, Inc. DEF 14A 2025CVKD DEF 14A 2025: proxy statement for fiscal 2025
- Cadrenal Therapeutics, Inc. DEF 14A 2024CVKD DEF 14A 2024: proxy statement for fiscal 2024
- Cadrenal Therapeutics, Inc. DEF 14A 2023CVKD DEF 14A 2023: proxy statement for fiscal 2023
- Cadrenal Therapeutics, Inc. DEF 14A 2022CVKD DEF 14A 2022: proxy statement for fiscal 2022
- Cadrenal Therapeutics, Inc. Form 4 2026CVKD Form 4 2026: insider trading filing for fiscal 2026
- Cadrenal Therapeutics, Inc. Form 4 2025CVKD Form 4 2025: insider trading filing for fiscal 2025
- Cadrenal Therapeutics, Inc. Form 4 2024CVKD Form 4 2024: insider trading filing for fiscal 2024
- Cadrenal Therapeutics, Inc. Form 4 2023CVKD Form 4 2023: insider trading filing for fiscal 2023
- Cadrenal Therapeutics, Inc. Form 4 2022CVKD Form 4 2022: insider trading filing for fiscal 2022
- Cadrenal Therapeutics, Inc. S-1 2026CVKD S-1 2026: registration statement for fiscal 2026
- Cadrenal Therapeutics, Inc. S-1 2025CVKD S-1 2025: registration statement for fiscal 2025
- Cadrenal Therapeutics, Inc. S-1 2024CVKD S-1 2024: registration statement for fiscal 2024
- Cadrenal Therapeutics, Inc. S-1 2023CVKD S-1 2023: registration statement for fiscal 2023
- Cadrenal Therapeutics, Inc. S-1 2022CVKD S-1 2022: registration statement for fiscal 2022
- Cadrenal Therapeutics, Inc. 13F 2026CVKD 13F 2026: institutional holdings for fiscal 2026
- Cadrenal Therapeutics, Inc. 13F 2025CVKD 13F 2025: institutional holdings for fiscal 2025
- Cadrenal Therapeutics, Inc. 13F 2024CVKD 13F 2024: institutional holdings for fiscal 2024
- Cadrenal Therapeutics, Inc. 13F 2023CVKD 13F 2023: institutional holdings for fiscal 2023
- Cadrenal Therapeutics, Inc. 13F 2022CVKD 13F 2022: institutional holdings for fiscal 2022
More companies